{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:04:07Z","timestamp":1791288247868,"version":"4.3.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.neuropharm.2012.05.019","type":"journal-article","created":{"date-parts":[[2012,5,24]],"date-time":"2012-05-24T21:00:10Z","timestamp":1337893210000},"page":"719-732","source":"Crossref","is-referenced-by-count":29,"title":["Activating mitochondrial regulator PGC-1\u03b1 expression by astrocytic NGF is a therapeutic strategy for Huntington's disease"],"prefix":"10.1016","volume":"63","author":[{"given":"Li-Wen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Yea","family":"Horng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ching","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Tsun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.05.019_bib1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s12640-009-9116-z","article-title":"Dysregulation of CREB activation and histone acetylation in 3-nitropropionic acid-treated cortical neurons: prevention by BDNF and NGF","volume":"17","author":"Almeida","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.neuron.2008.10.013","article-title":"The mystery and magic of glia: a perspective on their roles in health and disease","volume":"60","author":"Barres","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.05.019_bib3","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1091\/mbc.e05-07-0607","article-title":"Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin","volume":"17","author":"Benchoua","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.neuropharm.2012.05.019_bib4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0301-0082(99)00005-2","article-title":"Replicating Huntington's disease phenotype in experimental animals","volume":"59","author":"Brouillet","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-6-1","article-title":"Localization of sequence variations in PGC-1alpha influence their modifying effect in Huntington disease","volume":"6","author":"Che","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/01.WCB.0000044631.80210.3C","article-title":"Astrocytes and brain injury","volume":"23","author":"Chen","year":"2003","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib7","doi-asserted-by":"crossref","first-page":"7288","DOI":"10.1523\/JNEUROSCI.17-19-07288.1997","article-title":"Disruption of a single allele of the nerve growth factor gene results in atrophy of basal forebrain cholinergic neurons and memory deficits","volume":"17","author":"Chen","year":"1997","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib8","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/nbt1008-1077","article-title":"New therapies from old medicines","volume":"26","author":"Chen","year":"2008","journal-title":"Nat. Biotech."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib9","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/hmg\/ddq322","article-title":"Modulation of energy deficiency in Huntington's disease via activation of the peroxisome proliferator-activated receptor gamma","volume":"19","author":"Chiang","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.nbd.2009.07.014","article-title":"CREB is a key regulator of striatal vulnerability in chemical and genetic models of Huntington's disease","volume":"36","author":"Choi","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-0186(03)00003-2","article-title":"Cholesterol deficiency increases the vulnerability of hippocampal glia in primary culture to glutamate-induced excitotoxicity","volume":"43","author":"Chou","year":"2003","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0197-4580(95)02026-8","article-title":"Levels of NGF, p75NGFR and ChAT immunoreactivity in brain of adult and aged microencephalic rats","volume":"17","author":"Cimino","year":"1996","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2012.05.019_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.05.019_bib14","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S1474-4422(07)70220-X","article-title":"Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial","volume":"6","author":"Di Prospero","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib15","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1523\/JNEUROSCI.12-04-01454.1992","article-title":"Endogenous NGF and nerve impulses regulate the collateral sprouting of sensory axons in the skin of the adult rat","volume":"12","author":"Diamond","year":"1992","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0197-4580(01)00238-X","article-title":"Plasticity of aged perivascular axons following exogenous NGF: analysis of catecholamines","volume":"23","author":"Dickason","year":"2002","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2012.05.019_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2144\/05381RR02","article-title":"Culture of adult mouse neurons","volume":"38","author":"Eide","year":"2005","journal-title":"Biotechniques"},{"key":"10.1016\/j.neuropharm.2012.05.019_bib18","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0306-4522(02)00205-1","article-title":"Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl\/6 mice: behavioural and histopathological characterisation","volume":"114","author":"Fernagut","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.05.019_bib19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1172\/JCI27794","article-title":"PGC-1 coactivators: inducible regulators of energy metabolism in health and disease","volume":"116","author":"Finck","year":"2006","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib20","series-title":"Methylxanthines","first-page":"235","article-title":"Propentofylline: glial modulation, neuroprotection, and alleviation of chronic pain","author":"Fredholm","year":"2011"},{"key":"10.1016\/j.neuropharm.2012.05.019_bib21","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/jnr.490350413","article-title":"Striatal degeneration induced by mitochondrial blockade is prevented by biologically delivered NGF","volume":"35","author":"Frim","year":"1993","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib22","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/BF00966824","article-title":"Ventricular injection of nerve growth factor increases dopamine content in the striata of MPTP-treated mice","volume":"17","author":"Garcia","year":"1992","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib23","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archneur.1992.00530350075022","article-title":"Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease","volume":"49","author":"Grafton","year":"1992","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib24","doi-asserted-by":"crossref","first-page":"8408","DOI":"10.1073\/pnas.91.18.8408","article-title":"Nerve growth factor-induced ocular dominance plasticity in adult cat visual cortex","volume":"91","author":"Gu","year":"1994","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0306-4522(96)00602-1","article-title":"Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid","volume":"79","author":"Guyot","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.05.019_bib26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/35093131","article-title":"CREB regulates hepatic gluconeogenesis through the coactivator PGC-1","volume":"413","author":"Herzig","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.05.019_bib27","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0028-3908(98)00048-3","article-title":"Evidence that nerve growth factor plays a role in long-term potentiation in the rat dentate gyrus","volume":"37","author":"Kelly","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.05.019_bib28","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.neuropharm.2004.12.013","article-title":"Protective effects of ginseng saponins on 3-nitropropionic acid-induced striatal degeneration in rats","volume":"48","author":"Kim","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.05.019_bib29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.410410206","article-title":"Energy metabolism defects in Huntington's disease and effects of coenzyme Q10","volume":"41","author":"Koroshetz","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib30","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","article-title":"Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha","volume":"127","author":"Lagouge","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.05.019_bib31","doi-asserted-by":"crossref","first-page":"40398","DOI":"10.1074\/jbc.C500140200","article-title":"Mitochondrial cyclic AMP response element-binding protein (CREB) mediates mitochondrial gene expression and neuronal survival","volume":"280","author":"Lee","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/jez.1401160206","article-title":"Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo","volume":"116","author":"Levi-Montalcini","year":"1951","journal-title":"J.\u00a0Exp. Zool."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cmet.2005.05.004","article-title":"Metabolic control through the PGC-1 family of transcription coactivators","volume":"1","author":"Lin","year":"2005","journal-title":"Cell Metab."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib34","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1523\/JNEUROSCI.16-15-04604.1996","article-title":"Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells","volume":"16","author":"Martinez-Serrano","year":"1996","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib35","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0197-4580(01)00345-1","article-title":"Amelioration of cholinergic neurons dysfunction in aged rats depends on the continuous supply of NGF","volume":"23","author":"Niewiadomska","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2012.05.019_bib36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0304-3940(93)90387-Z","article-title":"Oral administration of idebenone, a stimulator of NGF synthesis, recovers reduced NGF content in aged rat brain","volume":"163","author":"Nitta","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/A:1020753629477","article-title":"3-Nitropropionic acid (3-NPA) produces hypothermia and inhibits histochemical labeling of succinate dehydrogenase (SDH) in rat brain","volume":"14","author":"Nony","year":"1999","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib38","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib39","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0169-328X(95)00250-V","article-title":"Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF","volume":"36","author":"Poduslo","year":"1996","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib40","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/archneurol.2008.588","article-title":"PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia","volume":"66","author":"Qin","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib41","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1073\/pnas.90.8.3602","article-title":"Proliferation, differentiation, and long-term culture of primary hippocampal neurons","volume":"90","author":"Ray","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuropharm.2012.05.019_bib42","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0166-2236(97)01139-9","article-title":"Reactive astrocytes: cellular and molecular cues to biological function","volume":"20","author":"Ridet","year":"1997","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib43","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2174\/138920109789978757","article-title":"Ganoderma lucidum: a potent pharmacological macrofungus","volume":"10","author":"Sanodiya","year":"2009","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib44","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/13518","article-title":"Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization","volume":"5","author":"Sawa","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib45","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/1097-4547(20010301)63:5<402::AID-JNR1035>3.0.CO;2-F","article-title":"Nerve growth factor prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced cell death via the Akt pathway by suppressing caspase-3-like activity using PC12 cells: relevance to therapeutical application for Parkinson's disease","volume":"63","author":"Shimoke","year":"2001","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib46","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1146\/annurev.neuro.24.1.1217","article-title":"Nerve growth factor signaling, neuroprotection, and neural repair","volume":"24","author":"Sofroniew","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib47","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A\u00a0novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.05.019_bib48","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm1239","article-title":"A\u00a0phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease","volume":"11","author":"Tuszynski","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib49","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/096368970000900508","article-title":"Intraparenchymal NGF infusions rescue degenerating cholinergic neurons","volume":"9","author":"Tuszynski","year":"2000","journal-title":"Cell Transplant."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib50","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib51","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0531-5131(03)01682-0","article-title":"Effects of Ganoderma on aging and learning and memory ability in senescence accelerated mice","volume":"1260","author":"Wang","year":"2004","journal-title":"Int. Congress Ser."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib52","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","article-title":"Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration","volume":"4","author":"Weydt","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib53","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0166-4328(97)86054-8","article-title":"Orally active NGF synthesis stimulators: potential therapeutic agents in alzheimer's disease","volume":"83","author":"Yamada","year":"1997","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib54","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jasms.2007.01.012","article-title":"Analysis of triterpenoids in Ganoderma lucidum using liquid chromatography coupled with electrospray ionization mass spectrometry","volume":"18","author":"Yang","year":"2007","journal-title":"J.\u00a0Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.neuropharm.2012.05.019_bib55","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.febslet.2005.01.046","article-title":"Free fatty acids increase PGC-1alpha expression in isolated rat islets","volume":"579","author":"Zhang","year":"2005","journal-title":"FEBS Lett."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812002171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812002171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T11:13:17Z","timestamp":1656069197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812002171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0028390812002171"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.05.019","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}